302 related articles for article (PubMed ID: 30030108)
1. Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review.
Chiba H; Otsuka M; Takahashi H
Respir Investig; 2018 Sep; 56(5):384-391. PubMed ID: 30030108
[TBL] [Abstract][Full Text] [Related]
2. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
5. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels.
Koga Y; Hachisu Y; Tsurumaki H; Yatomi M; Kaira K; Ohta S; Ono J; Izuhara K; Dobashi K; Hisada T
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31108995
[No Abstract] [Full Text] [Related]
7. [PROGNOSTIC VALUE OF BLOOD AND BRONCHOALVEOLAR LAVAGE FLUIDS BIOMARKERS FOR IDIOPATHIC PULMONARY FYBROSIS (REVIEW)].
Yakovleva О; Klekot А; Shcherbeniuk N; Hoina-Kardasevich O
Georgian Med News; 2019 Sep; (294):98-103. PubMed ID: 31687958
[TBL] [Abstract][Full Text] [Related]
8. Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis.
Nishikiori H; Chiba H; Ariki S; Kuronuma K; Otsuka M; Shiratori M; Ikeda K; Watanabe A; Kuroki Y; Takahashi H
BMC Pulm Med; 2014 Dec; 14():196. PubMed ID: 25488319
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in idiopathic pulmonary fibrosis.
Zhang Y; Kaminski N
Curr Opin Pulm Med; 2012 Sep; 18(5):441-6. PubMed ID: 22847105
[TBL] [Abstract][Full Text] [Related]
10. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
Song JW; Do KH; Jang SJ; Colby TV; Han S; Kim DS
Chest; 2013 May; 143(5):1422-1429. PubMed ID: 23715088
[TBL] [Abstract][Full Text] [Related]
11. Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan.
Ikeda K; Chiba H; Nishikiori H; Azuma A; Kondoh Y; Ogura T; Taguchi Y; Ebina M; Sakaguchi H; Miyazawa S; Suga M; Sugiyama Y; Nukiwa T; Kudoh S; Takahashi H;
Respir Res; 2020 Nov; 21(1):316. PubMed ID: 33256760
[TBL] [Abstract][Full Text] [Related]
12. Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan.
Huang H; Peng X; Nakajima J
Biosci Trends; 2013 Aug; 7(4):172-7. PubMed ID: 24056167
[TBL] [Abstract][Full Text] [Related]
13. Blood Biomarkers in Idiopathic Pulmonary Fibrosis.
Guiot J; Moermans C; Henket M; Corhay JL; Louis R
Lung; 2017 Jun; 195(3):273-280. PubMed ID: 28353114
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers--insights from the bench side.
Borensztajn K; Crestani B; Kolb M
Respiration; 2013; 86(6):441-52. PubMed ID: 24356558
[TBL] [Abstract][Full Text] [Related]
15. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.
Huang TH; Kuo CW; Chen CW; Tseng YL; Wu CL; Lin SH
BMC Pulm Med; 2021 May; 21(1):165. PubMed ID: 33992083
[TBL] [Abstract][Full Text] [Related]
16. Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Wang K; Ju Q; Cao J; Tang W; Zhang J
Medicine (Baltimore); 2017 Jun; 96(23):e7083. PubMed ID: 28591049
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
[TBL] [Abstract][Full Text] [Related]
18. The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
Samukawa T; Hamada T; Uto H; Yanagi M; Tsukuya G; Nosaki T; Maeda M; Hirano T; Tsubouchi H; Inoue H
BMC Pulm Med; 2012 Sep; 12():55. PubMed ID: 22963039
[TBL] [Abstract][Full Text] [Related]
19. C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.
Vuga LJ; Tedrow JR; Pandit KV; Tan J; Kass DJ; Xue J; Chandra D; Leader JK; Gibson KF; Kaminski N; Sciurba FC; Duncan SR
Am J Respir Crit Care Med; 2014 Apr; 189(8):966-74. PubMed ID: 24628285
[TBL] [Abstract][Full Text] [Related]
20. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
Kinder BW; Brown KK; McCormack FX; Ix JH; Kervitsky A; Schwarz MI; King TE
Chest; 2009 Jun; 135(6):1557-1563. PubMed ID: 19255294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
